See Intervention Description) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02670161 (ClinicalTrials.gov) | May 2016 | 23/1/2016 | Quality Improvement and Practice Based Research in Neurology Using the EMR | Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record | Brain Tumors;Epilepsy;Migraine;Mild Cognitive Impairment;Concussion;Multiple Sclerosis;Neuropathy;Parkinson's;Restless Legs Syndrome;Stroke | Drug: Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description) | NorthShore University HealthSystem | NULL | Enrolling by invitation | 18 Years | 100 Years | All | 3300 | Phase 4 | NULL |